Literature DB >> 10666173

Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells.

J F Maillefert1, O Duchamp, E Solary, P Genne, C Tavernier.   

Abstract

BACKGROUND: The multidrug resistance phenomenon results from the expression of P-glycoprotein (P-gp), a drug-efflux pump. Corticosteroids are substrates for P-gp, whose function can be inhibited by cyclosporin. This study evaluates the ability of cyclosporin to modulate dexamethasone uptake in multidrug resistant cells.
METHODS: The K 562 cell line, which does not express P-gp and a P-gp expressing clone, K562/ADM, were used. Cells were incubated with H3-dexamethasone in the absence or presence of cyclosporin at various concentrations. Then, cells were washed, lysed, and radioactivity was measured.
RESULTS: The uptake of dexamethasone alone was higher in sensitive than in resistant cells. Addition of cyclosporin induced a dose dependent increase of dexamethasone uptake in resistant cells, whereas the drug did not influence dexamethasone uptake in parental cells.
CONCLUSION: Cyclosporin, at therapeutic concentrations induces a moderate, but significant increase in dexamethasone accumulation in multidrug resistant cells. Thus, cyclosporin might increase the intestinal absorption of corticosteroids or their accumulation in mononuclear cells, or both, thereby increasing their therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666173      PMCID: PMC1753060          DOI: 10.1136/ard.59.2.146

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Drug resistance in rheumatology: an area in search of investigators.

Authors:  Frank A Wollheim
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 2.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis.

Authors:  V Agarwal; S K Mittal; R Misra
Journal:  Clin Rheumatol       Date:  2009-01-10       Impact factor: 2.980

4.  Contribution of patient related differences to multidrug resistance in rheumatoid arthritis.

Authors:  C Morgan; M Lunt; H Brightwell; P Bradburn; W Fallow; M Lay; A Silman; I N Bruce
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.